Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma
Authors:
- David S. PearlmanDPDavid S. Pearlman
- Martha V. WhiteMWMartha V. White
- Allen K. LiebermanALAllen K. Lieberman
- Pamela J. PepsinPPPamela J. Pepsin
- Chris KalbergCKChris Kalberg
- Amanda EmmettAEAmanda Emmett
- Brian BowersBBBrian Bowers
- Kathleen A. RickardKRKathleen A. Rickard
- Paul DorinskyPDPaul Dorinsky
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (2) , 227-235
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukastJournal of Allergy and Clinical Immunology, 2000
- Salmeterol/fluticasone propionate (50500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthmaRespiratory Medicine, 1999
- The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1999
- The complementary role of glucocorticosteroids and long‐acting β‐adrenergic agonistsAllergy, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994